Kevin Hagan, president and CEO of the PAN Foundation, discusses how pharma can help Medicaare patients post-IRA reform.
Kevin Hagan, president and CEO of the PAN Foundation, discusses how pharma can help Medicare patients post-IRA reform. Hagan notes there is a continuing need to have copay assistance because Medicare patients still face a $2K out of pocket cost, which is still a challenge for many of them.
Visit the PAN Foundation’s Education hub for patients providers and industry on the PAN website.
Source link
#Pharma #Patients #Post #IRA
